Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

• Prif Awduron: Nick Scott (Awdur), Samuel W. Hainsworth (Awdur), Rachel Sacks-Davis (Awdur), Alisa Pedrana (Awdur), Joseph Doyle (Awdur), Amanda Wade (Awdur), Margaret Hellard (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2018-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background and aim: Direct-acting antiviral (DAA) treatments became available for all people living with hepatitis C virus (HCV) in Australia in March 2016. We assess variations in treatment rates and prescribing patterns across Australia's 338 Statistical Area 3 (SA3) geographical units. Metho...